RED-HF (Completed)

Reduction of Events with Darbepoetin alfa in Heart Failure. A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Subjects With HF and Anemia.